A New FGF21 Analog for the Treatment of Fatty Liver Disease

被引：8
|
作者：
Kleinert, Maximilian [1 ,2 ,3 ]
Mueller, Timo D. [1 ,2 ,4 ]
机构：
[1] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr HDC, Inst Diabet & Obes, Neuherberg, Germany
[2] German Natl Diabet Ctr DZD, Neuherberg, Germany
[3] Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark
[4] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Pharmacogen, Dept Pharmacol Expt Therapy & Toxicol, Tubingen, Germany
来源：
DIABETES | 2020年 / 69卷 / 08期
关键词：
RISK;
D O I：
10.2337/dbi20-0025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1605 / 1607
页数：3
相关论文
共 50 条
  • [1] Fatty liver and FGF21 physiology
    Maratos-Flier, Eleftheria
    EXPERIMENTAL CELL RESEARCH, 2017, 360 (01) : 2 - 5
  • [2] FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy
    Shenglong Zhu
    Yunzhou Wu
    Xianlong Ye
    Lei Ma
    Jianying Qi
    Dan Yu
    Yuquan Wei
    Guangxiao Lin
    Guiping Ren
    Deshan Li
    Molecular and Cellular Biochemistry, 2016, 420 : 107 - 119
  • [3] FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy
    Zhu, Shenglong
    Wu, Yunzhou
    Ye, Xianlong
    Ma, Lei
    Qi, Jianying
    Yu, Dan
    Wei, Yuquan
    Lin, Guangxiao
    Ren, Guiping
    Li, Deshan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 420 (1-2) : 107 - 119
  • [4] FGF21 AND METABOLIC DISEASE IN 2016 A new frontier in FGF21 biology
    Potthoff, Matthew J.
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (02) : 74 - 76
  • [5] Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
    Yilmaz, Yusuf
    Eren, Fatih
    Yonal, Oya
    Kurt, Ramazan
    Aktas, Bilge
    Celikel, Cigdem Ataizi
    Ozdogan, Osman
    Imeryuz, Nese
    Kalayci, Cem
    Avsar, Erol
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (10) : 887 - 892
  • [6] Role of plasma FGF21 as a biomarker for nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH)
    Bril, Fernando
    Lomonaco, Romina
    Orsak, Beverly
    Chang, Zhi
    Ortiz-Lopez, Carolina
    Hecht, Joan
    Tio, Fermin
    Cusi, Kenneth
    HEPATOLOGY, 2013, 58 : 487A - 487A
  • [7] Clinical significance of serum FGF21 levels in diagnosing nonalcoholic fatty liver disease early
    Kai Xu
    Bo-Wu He
    Jian-Ling Yu
    Hui-Min Kang
    Ting-Ting Zheng
    Zhi-Yun Chen
    Jian-Shuang Li
    Scientific Reports, 14 (1)
  • [8] Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
    Chikamatsu, Mayuko
    Watanabe, Hiroshi
    Shintani, Yuhi
    Murata, Ryota
    Miyahisa, Masako
    Nishinoiri, Ayano
    Imafuku, Tadashi
    Takano, Mei
    Arimura, Nanaka
    Yamada, Kohichi
    Kamimura, Miya
    Mukai, Baki
    Satoh, Takao
    Maeda, Hitoshi
    Maruyama, Toru
    JOURNAL OF CONTROLLED RELEASE, 2023, 355 : 42 - 53
  • [9] regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease
    Yueh, Mei-Fei
    He, Feng
    Chen, Chen
    Vu, Catherine
    Tripathi, Anupriya
    Knight, Rob
    Karin, Michael
    Chen, Shujuan
    Tukey, Robert H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (49) : 31259 - 31266
  • [10] FGF21 and Chronic Kidney Disease
    Salgado, Joao Victor
    Goes, Miguel Angelo
    Filho, Natalino Salgado
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 118
12345